An observational study in Ischemic Cardiovascular Disease, sponsored by Cardiocentro Ticino. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-05-08.
Sponsored by Cardiocentro Ticino · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Stress, Psychological with a site in Switzerland — 2 open to participants now, 2 under way, none of them phase 3. Stress, Psychological · Switzerland.
Among the 17 studies in Stress, Psychological with a site in Switzerland, this one is the only one that started in 2023, is one of 5 observational ones, and was the 15th registered.
854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.
Browse Stress, Psychological studies →2 of the 17 studies in Stress, Psychological with a site in Switzerland are open now. Recruiting first, the newest first:
Sara L. Kroll · Sites in Switzerland
Ages 18–40 · Healthy volunteers
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 200 across 146 observational studies indexed under Stress, Psychological.
Median enrollment 67 across the 12 interventional studies, 45 across the 5 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
Cardiocentro Ticino is the lead sponsor of 13 studies on the registry; 8 are open to participants now.
Cardiocentro Ticino has 1 study filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
1 of the studies in Stress, Psychological with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07778511Sara L. KrollHow Does the Opioid System Shape Stress and Social Behaviour in Men and Women and What Role Does Childhood Unpredictability Play? | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Stress, Psychological with a site in Switzerland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this trial is to investigate the coping strategies/physiological flexibility construct in patients hospitalized for ischemic cardiovascular disease and the possible association with recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up, the patient's decision to participate to clinical trials approved in the center and the adherence to cardiovascular medications.
Patients with age ≥ 18 years old and admission to the hospital for ischemic cardiovascular disease.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
coping strategies and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization)
coping strategies (evaluated using Brief COPE test) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization)
Time frame: 2 years (±14 days) from index hospitalization
psychological flexibility and the recurrence any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization)
psychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization)
Time frame: 2 years (±14 days) from index hospitalization
coping strategies and the patient's decision to participate to the clinical trials approved in the centres
coping strategies (evaluated using Brief COPE test) and the patient's decision to participate to the clinical trials approved in the centres
Time frame: at discharge of index hospitalization (up to 4 weeks)
psychological flexibility and the patient's decision to participate to the clinical trials approved in the centres
psychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the patient's decision to participate to the clinical trials approved in the centres
Time frame: at discharge of index hospitalization (up to 4 weeks)
coping strategies and the adherence to cardiovascular medications
coping strategies (evaluated using Brief COPE test) and the adherence to cardiovascular medications
Time frame: 2 years (±14 days) from index hospitalization
psychological flexibility and the adherence to cardiovascular medications
psychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the adherence to cardiovascular medications
Time frame: 2 years (±14 days) from index hospitalization
each coping strategy and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death
each coping strategy (evaluated using Brief COPE test) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death)
Time frame: 2 years (±14 days) from index hospitalization
each component of psychological flexibility model and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death
each component of psychological flexibility model (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death)
Time frame: 2 years (±14 days) from index hospitalization
each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial
each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed
Time frame: at discharge of index hospitalization (up to 4 weeks)
each component of psychological flexibility and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial
each component of psychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed
Time frame: at discharge of index hospitalization (up to 4 weeks)
cognitive fusion and recurrence of cardiovascular events
cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and recurrence of cardiovascular events
Time frame: at 2 years (±14 days) from index hospitalization
cognitive fusion and participation to the trials
cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and participation to the trials
Time frame: at discharge of index hospitalization (up to 4 weeks)
cognitive fusion and adherence to cardiovascular medications
cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and adherence to cardiovascular medications
Time frame: at 2 years (±14 days) from index hospitalization
psychological flexibility evaluated with CVD-AAQ test and cardiovascular events
psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and cardiovascular events
Time frame: at 2 years (±14 days) from index hospitalization
psychological flexibility evaluated with CVD-AAQ test and participation to the trials
psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and participation to the trials
Time frame: at discharge of index hospitalization (up to 4 weeks)
psychological flexibility evaluated with CVD-AAQ test and adherence to cardiovascular medications
psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and adherence to cardiovascular medications
Time frame: at 2 years (±14 days) from index hospitalization
Started Feb 2023 (actual). Primary completion is estimated for Dec 2025, 34 months after the start.
Of 60 non-industry observational studies under Stress, Psychological, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 57. This study's planned 34 months is above that.
Counting every sponsor, half of 64 studies reached it within 23 months; a quarter within 6 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cardiocentro Ticino